A new member of the ETS family fused to EWS in Ewing tumors - PubMed
- ️Wed Jan 01 1997
. 1997 Mar 13;14(10):1159-64.
doi: 10.1038/sj.onc.1200933.
Affiliations
- PMID: 9121764
- DOI: 10.1038/sj.onc.1200933
A new member of the ETS family fused to EWS in Ewing tumors
M Peter et al. Oncogene. 1997.
Abstract
As a result of chromosome translocations, the EWS gene is fused to a variety of transcription factors in human solid neoplasia. In Ewing tumors EWS can be fused to four different members of the ETS family, namely FLI-1, ERG, ETV1 and E1AF. We have identified a new member of the ETS family, called FEV, which is fused to EWS in a subset of Ewing tumors. FEV encodes a 238 amino acid protein which contains an ETS DNA binding domain closely related to that of FLI-1 and ERG. However, the N-terminal portion of FEV is only 42 amino acids long which suggests that FEV is lacking important transcription regulatory domains contained in FLI-1 and ERG N-terminal parts. The C-terminal end of FEV is rich in alanine residues which may indicate that FEV is a transcription repressor. The FEV gene is encoded by three exons and is located on chromosome 2. FEV expression was only detected in adult prostate and small intestine but not in other adult nor in fetal tissues, thus indicating that FEV has a restricted expression pattern. Following a scheme similar to previously described translocations in Ewing tumors, a t(2;22) chromosome translocation fuses the N-terminal domain of EWS to the ETS DNA binding domain of FEV.
Similar articles
-
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN. Jeon IS, et al. Oncogene. 1995 Mar 16;10(6):1229-34. Oncogene. 1995. PMID: 7700648
-
Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. Sorensen PH, et al. Nat Genet. 1994 Feb;6(2):146-51. doi: 10.1038/ng0294-146. Nat Genet. 1994. PMID: 8162068
-
Fukuma M, Okita H, Hata J, Umezawa A. Fukuma M, et al. Oncogene. 2003 Jan 9;22(1):1-9. doi: 10.1038/sj.onc.1206055. Oncogene. 2003. PMID: 12527902
-
Biology of EWS/ETS fusions in Ewing's family tumors.
Arvand A, Denny CT. Arvand A, et al. Oncogene. 2001 Sep 10;20(40):5747-54. doi: 10.1038/sj.onc.1204598. Oncogene. 2001. PMID: 11607824 Review.
-
Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, Squire JA. Maire G, et al. Cancer Genet Cytogenet. 2008 Mar;181(2):81-92. doi: 10.1016/j.cancergencyto.2007.11.002. Cancer Genet Cytogenet. 2008. PMID: 18295659 Review.
Cited by
-
Targeted therapy in Ewing sarcoma.
Lissat A, Chao MM, Kontny U. Lissat A, et al. ISRN Oncol. 2012;2012:609439. doi: 10.5402/2012/609439. Epub 2012 May 28. ISRN Oncol. 2012. PMID: 22690342 Free PMC article.
-
Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.
Asfa S, Toy HI, Arshinchi Bonab R, Chrousos GP, Pavlopoulou A, Geronikolou SA. Asfa S, et al. Int J Environ Res Public Health. 2023 Jul 3;20(13):6288. doi: 10.3390/ijerph20136288. Int J Environ Res Public Health. 2023. PMID: 37444135 Free PMC article.
-
Vellichirammal NN, Chaturvedi NK, Joshi SS, Coulter DW, Guda C. Vellichirammal NN, et al. Cancer Lett. 2021 Feb 28;499:24-38. doi: 10.1016/j.canlet.2020.11.015. Epub 2020 Nov 25. Cancer Lett. 2021. PMID: 33248210 Free PMC article. Review.
-
Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK. Harms PW, et al. J Invest Dermatol. 2013 Apr;133(4):936-45. doi: 10.1038/jid.2012.445. Epub 2012 Dec 6. J Invest Dermatol. 2013. PMID: 23223137 Free PMC article.
-
Tajima S, Ohkubo A, Yoshida M, Koda K, Nameki I. Tajima S, et al. Int J Clin Exp Pathol. 2015 Jan 1;8(1):960-6. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials